TRENTON, N.J. — Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company’s medicines.
Ranbaxy, a subsidiary of Ranbaxy Laboratories Ltd., India’s biggest drugmaker, is operating under increased scrutiny from the U.S. Food and Drug Administration because of quality lapses at multiple Ranbaxy factories over the past several years. The FDA also has alleged the company lied about test results for more than two dozen of its generic drugs several years ago.
On Friday, Ranbaxy posted a notice on its U.S. website, saying it’s recalling 10-, 20- and 40-milligram doses of tablets of atorvastatin calcium. That’s generic Lipitor, the cholesterol fighter that reigned for years as the world’s top-selling drug.
The recall includes 41 lots of the drug, nearly all with 90 pills per bottle, but three lots contain 500 pills per bottle. It’s unclear how many bottles are in each lot, but medicine batches typically contain many thousands of pills. The 80-milligram strength tablets are not affected.
A Ranbaxy spokesman did not immediately respond to messages from The Associated Press seeking further information.
A list of the recalled lots is online at http://bit.ly/TT5tlm
related articles »
TRENTON, N.J. — If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few ...
WASHINGTON — The discovery that a fake version of the widely used cancer medicine Avastin is circulating in the United ...
Chances are, you know someone who is taking a cholesterol lowering drug. If you do, there's a good chance that ...
The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months ...
